Kate Weiss
0000-0003-4860-7285
Publication & Citation Trends
Publications
36 total
34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
Cited by 0
Semantic Scholar
Hypoxia and tumor associated macrophages shape response to immune and angiogenesis-targeted therapies in metastatic clear cell renal cell carcinoma 3738
Cited by 0
Semantic Scholar
Abstract B029: Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
Cited by 0
Semantic Scholar
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies PDF
Cited by 114
OpenAlex
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade PDF
Cited by 31
OpenAlex
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas PDF
Cited by 24
OpenAlex
Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies PDF
Cited by 5
OpenAlex
Associations between body composition features and clinical outcomes in metastatic clear cell renal cell carcinoma patients treated with immune checkpoint blockade. OA
Cited by 15
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(26)
Cancer Immunotherapy and Biomarkers
(15)
Renal and related cancers
(8)
Pancreatic and Hepatic Oncology Research
(6)
Cancer Genomics and Diagnostics
(6)
Affiliations
Memorial Sloan Kettering Cancer Center
Kettering University
University of Rochester